Cargando…

Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)

BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jie, Xing, Pengfei, Zhu, Xucheng, Chen, Ronghua, Shao, Huaming, Xuan, Jinggang, Jiang, Tianwei, Yang, Pengfei, Zhang, Yongwei, Li, Zifu, Chen, Wenhuo, Li, Tianxiao, Wang, Shouchun, Lou, Min, Peng, Ya, Liu, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730510/
https://www.ncbi.nlm.nih.gov/pubmed/36504640
http://dx.doi.org/10.3389/fneur.2022.1013819
_version_ 1784845688574574592
author Cao, Jie
Xing, Pengfei
Zhu, Xucheng
Chen, Ronghua
Shao, Huaming
Xuan, Jinggang
Jiang, Tianwei
Yang, Pengfei
Zhang, Yongwei
Li, Zifu
Chen, Wenhuo
Li, Tianxiao
Wang, Shouchun
Lou, Min
Peng, Ya
Liu, Jianmin
author_facet Cao, Jie
Xing, Pengfei
Zhu, Xucheng
Chen, Ronghua
Shao, Huaming
Xuan, Jinggang
Jiang, Tianwei
Yang, Pengfei
Zhang, Yongwei
Li, Zifu
Chen, Wenhuo
Li, Tianxiao
Wang, Shouchun
Lou, Min
Peng, Ya
Liu, Jianmin
author_sort Cao, Jie
collection PubMed
description BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize Acute Ischaemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals (DIRECT-MT). The primary outcome was the 90-day modified Rankin Scale (mRS) score. Five subgroups of cardioembolic stroke patients were analyzed. A multivariable ordinal logistic regression analysis analyzed the difference in the primary outcome between the direct mechanical thrombectomy (MT) and bridging therapy groups. An interaction term was entered into the model to test for subgroup interaction. The DIRECT-MT trial is registered with clinicaltrials.gov Identifier: NCT03469206. RESULTS: A total of 290 CE stroke patients from the DIRECT-MT trial were enrolled in this study: 146 patients in the direct MT group and 144 patients in the bridging therapy group. No difference between the two treatment groups in the primary outcome was found (adjusted common odds ratio, 1.218; 95% confidence interval, 0.806 to 1.841; P = 0.34). In the subgroup analysis, CE stroke patients with an NIHSS ≤ 15 in the direct MT group were associated with better outcomes (47 vs. 53, acOR, 3.14 [1.497, 6.585]) and lower mortality (47 vs. 53, aOR, 0.16 [0.026, 0.986]) than those in the bridging therapy group, while there were no significant differences between the two treatment groups in the outcome and mortality of CE stroke patients with an NIHSS >15. CONCLUSION: Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy. This need to be confirmed by further prospective studies in a larger number of patients.
format Online
Article
Text
id pubmed-9730510
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97305102022-12-09 Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT) Cao, Jie Xing, Pengfei Zhu, Xucheng Chen, Ronghua Shao, Huaming Xuan, Jinggang Jiang, Tianwei Yang, Pengfei Zhang, Yongwei Li, Zifu Chen, Wenhuo Li, Tianxiao Wang, Shouchun Lou, Min Peng, Ya Liu, Jianmin Front Neurol Neurology BACKGROUND: The benefit of intravenous alteplase before endovascular thrombectomy is unclear in patients with acute cardioembolic stroke. METHODS: We collected cardioembolic (CE) stroke patient data from the multicentre randomized clinical trial of Direct Intra-arterial Thrombectomy to Revascularize Acute Ischaemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals (DIRECT-MT). The primary outcome was the 90-day modified Rankin Scale (mRS) score. Five subgroups of cardioembolic stroke patients were analyzed. A multivariable ordinal logistic regression analysis analyzed the difference in the primary outcome between the direct mechanical thrombectomy (MT) and bridging therapy groups. An interaction term was entered into the model to test for subgroup interaction. The DIRECT-MT trial is registered with clinicaltrials.gov Identifier: NCT03469206. RESULTS: A total of 290 CE stroke patients from the DIRECT-MT trial were enrolled in this study: 146 patients in the direct MT group and 144 patients in the bridging therapy group. No difference between the two treatment groups in the primary outcome was found (adjusted common odds ratio, 1.218; 95% confidence interval, 0.806 to 1.841; P = 0.34). In the subgroup analysis, CE stroke patients with an NIHSS ≤ 15 in the direct MT group were associated with better outcomes (47 vs. 53, acOR, 3.14 [1.497, 6.585]) and lower mortality (47 vs. 53, aOR, 0.16 [0.026, 0.986]) than those in the bridging therapy group, while there were no significant differences between the two treatment groups in the outcome and mortality of CE stroke patients with an NIHSS >15. CONCLUSION: Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy. This need to be confirmed by further prospective studies in a larger number of patients. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9730510/ /pubmed/36504640 http://dx.doi.org/10.3389/fneur.2022.1013819 Text en Copyright © 2022 Cao, Xing, Zhu, Chen, Shao, Xuan, Jiang, Yang, Zhang, Li, Chen, Li, Wang, Lou, Peng and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Cao, Jie
Xing, Pengfei
Zhu, Xucheng
Chen, Ronghua
Shao, Huaming
Xuan, Jinggang
Jiang, Tianwei
Yang, Pengfei
Zhang, Yongwei
Li, Zifu
Chen, Wenhuo
Li, Tianxiao
Wang, Shouchun
Lou, Min
Peng, Ya
Liu, Jianmin
Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title_full Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title_fullStr Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title_full_unstemmed Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title_short Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: A subgroup analysis of a randomized clinical trial (DIRECT-MT)
title_sort mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: a subgroup analysis of a randomized clinical trial (direct-mt)
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730510/
https://www.ncbi.nlm.nih.gov/pubmed/36504640
http://dx.doi.org/10.3389/fneur.2022.1013819
work_keys_str_mv AT caojie mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT xingpengfei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT zhuxucheng mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT chenronghua mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT shaohuaming mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT xuanjinggang mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT jiangtianwei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT yangpengfei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT zhangyongwei mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT lizifu mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT chenwenhuo mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT litianxiao mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT wangshouchun mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT loumin mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT pengya mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt
AT liujianmin mildandmoderatecardioembolicstrokepatientsmaybenefitmorefromdirectmechanicalthrombectomythanbridgingtherapyasubgroupanalysisofarandomizedclinicaltrialdirectmt